ThursdayJul 16, 2020 12:54 pm

DarioHealth Corp. (NASDAQ: DRIO) Named Global Player in Digital Diabetes Management Market

The company was named to the list of BioSpace Movers and Shakers in July 2020 after veteran health plan executive Dennis A. Matheis joined its Board of Directors Global digital diabetes management market is projected to register CAGR of 17.8% by 2026 DarioHealth’s platform lauded for centering on continual maximization of patient engagement DarioHealth (NASDAQ: DRIO), a global digital therapeutics company serving its users with dynamic mobile health solutions, is in the spotlight as a major global player in the digital diabetes management market. A recent report published by Data Bridge Market Research featured DarioHealth and its advancements in digital…

Continue Reading

TuesdayJul 14, 2020 11:44 am

QualityStocksNewsBreaks – Why DarioHealth Corp. (NASDAQ: DRIO) Is ‘One to Watch’

DarioHealth (NASDAQ: DRIO) is a pioneer in the global digital therapeutics market focused on delivering evidence-based interventions to people with chronic conditions. A recent article discussing DarioHealth reads, “Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.” To view the full article, visit http://ibn.fm/5G5Ik About DarioHealth Corp. DarioHealth is a leading, global, digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality…

Continue Reading

TuesdayJul 07, 2020 11:41 am

DarioHealth Corp. (NASDAQ: DRIO) is “One to Watch”

Dario’s popular (4.9 stars on the Apple App Store and 11,000 reviews) chronic condition management platform addresses a $72 billion annual U.S. market opportunity There are roughly 51,000 active users of the Dario platform, including its proprietary medical device, mobile application, and digital and human coaching services Clinical studies show Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension) Patient engagement in therapies leads to health success. The Dario platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario smartphone-connected medical devices…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered